These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 21914810)
1. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. Rapley J; Oshiro N; Ortiz-Vega S; Avruch J J Biol Chem; 2011 Nov; 286(44):38043-38053. PubMed ID: 21914810 [TBL] [Abstract][Full Text] [Related]
2. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883 [TBL] [Abstract][Full Text] [Related]
3. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. Fonseca BD; Smith EM; Lee VH; MacKintosh C; Proud CG J Biol Chem; 2007 Aug; 282(34):24514-24. PubMed ID: 17604271 [TBL] [Abstract][Full Text] [Related]
5. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis. Mi W; Ye Q; Liu S; She QB Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827 [TBL] [Abstract][Full Text] [Related]
6. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
7. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. Wang L; Harris TE; Roth RA; Lawrence JC J Biol Chem; 2007 Jul; 282(27):20036-44. PubMed ID: 17510057 [TBL] [Abstract][Full Text] [Related]
8. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. Wang L; Harris TE; Lawrence JC J Biol Chem; 2008 Jun; 283(23):15619-27. PubMed ID: 18372248 [TBL] [Abstract][Full Text] [Related]
9. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. Thedieck K; Polak P; Kim ML; Molle KD; Cohen A; Jenö P; Arrieumerlou C; Hall MN PLoS One; 2007 Nov; 2(11):e1217. PubMed ID: 18030348 [TBL] [Abstract][Full Text] [Related]
10. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. Sato T; Nakashima A; Guo L; Tamanoi F J Biol Chem; 2009 May; 284(19):12783-91. PubMed ID: 19299511 [TBL] [Abstract][Full Text] [Related]
11. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280 [TBL] [Abstract][Full Text] [Related]
13. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
14. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947 [TBL] [Abstract][Full Text] [Related]
15. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion. Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619 [TBL] [Abstract][Full Text] [Related]
16. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Sancak Y; Thoreen CC; Peterson TR; Lindquist RA; Kang SA; Spooner E; Carr SA; Sabatini DM Mol Cell; 2007 Mar; 25(6):903-15. PubMed ID: 17386266 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815 [TBL] [Abstract][Full Text] [Related]
18. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
19. Intestinal cell kinase (ICK) promotes activation of mTOR complex 1 (mTORC1) through phosphorylation of Raptor Thr-908. Wu D; Chapman JR; Wang L; Harris TE; Shabanowitz J; Hunt DF; Fu Z J Biol Chem; 2012 Apr; 287(15):12510-9. PubMed ID: 22356909 [TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition. Dunlop EA; Dodd KM; Seymour LA; Tee AR Cell Signal; 2009 Jul; 21(7):1073-84. PubMed ID: 19272448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]